The detection of a mobile device that can diagnose the early diseases of Alzheimer's and Parkinson

An international team of researchers revealed a mobile sensor that would be “revolution” in the early detection and diagnosis of Alzheimer’s and Parkinson’s diseases, without the necessary extensive checks that sometimes need surgery. According to the study published in the Journal of the American Academy of Sciences, this device is an excellent jump in diagnostic technologies. The device can discover specific important indicators of neurological degenerative diseases, and transfer the results wirelessly to laptops or smartphones. The device represents a “decisive step” towards easy and non -surgical tests at home, or in care facilities such as clinics and homes around the world. The team tested the device on patients of patients from patients and showed that it was “accurate as the latest technology”. Researchers plan to test saliva and urine samples using a biological sensor, and the device can be adjusted to detect important indicators for other cases. The innovation of this diagnostic system depends on electrical, not chemical tracking methods, which provides a more practical and accurate method to identify important nerve degenerative indicators. The researchers say the diagnostic method on which the device relies “is easier to implement and more accurate.” By performing tests and the mobile diagnostic system, it can allow at home tests and at care points, such as clinics and homes for the elderly, for nerve degenerative diseases worldwide. The latest current test methods for Alzheimer’s and Parkinson disease require spinal pasture and photography tests, including MRI. As a result, early detection of the disease is difficult as patients reject these extensive and expensive surgical tests. The test is also difficult for patients who already have symptoms, and they have problems with movement, as well as those who do not have early access to local hospitals or medical facilities. He revealed the vital signs of the disease and alzheimer’s disease results in the accumulation and gathering of toxic proteins, “amyloid” bptimics “and” too “particulars, so the researchers developed a test able to detect the amyloid beta and the tau bitids, which are the vital indicators of Alzheimer’s Disease, Alpha Senklin Proteins, The Vital Mark of Parkinson’s Disease; associated with the Bita, Tau or Senoclin protein. prevent. “A reliable result” and the search team tested the apparatus using the amyloid protein that was derived from the brain of Alzheimer’s patients and died Parkinson disease. Experiments showed that vital sensors could discover the important indicators specified in both cases with great accuracy, just as with the latest current methods. The device also works with very low concentrations, which means it needs small amounts of samples, to only a few microlitures. In addition, the tests showed that the performance of the device was good, even when the samples analyzed contained other proteins. The discovery of Tao proteins was more difficult. But because the device looks at three different important indicators, it can merge the results of the three to draw a reliable comprehensive conclusion.